Moving Medical Semeiotics to the Digital Realm - SEMEOTICONS Approach to Face Signs of Cardiometabolic Risk

In modern medicine signs derivable from face observation remain an important part of the physical examination that, together with the anamnesis, constitutes the basis for a rational decision-making. Therefore, face semiotics may be considered as a potential source of information for obtaining markers of obesity, metabolomics, cardiovascular homeostasis and psychophysical status. Once properly mapped to computational descriptors, their systematic exploitation is expected allowing the building of effective self-monitoring systems. In this perspective, in the frame of the FP7 project SEMEOTICONS, the most relevant face signs of cardio-metabolic risk are reviewed and analysed so as to drive their detection, quantification and integration into a virtual individual model useful for cardio-metabolic risk prevention.

[1]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[2]  John A Spertus,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Executive Summary , 2005, Critical pathways in cardiology.

[3]  N. Saranummi,et al.  Rethinking Health: ICT-Enabled Services to Empower People to Manage Their Health , 2011, IEEE Reviews in Biomedical Engineering.

[4]  Volkan Ozduran,et al.  Global risk scores and exercise testing for predicting all-cause mortality in a preventive medicine program. , 2004, JAMA.

[5]  J. Barendregt,et al.  Global burden of disease , 1997, The Lancet.

[6]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.

[7]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[8]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[9]  Rafael Perera,et al.  What are the basic self-monitoring components for cardiovascular risk management? , 2010, BMC medical research methodology.

[10]  Lisa Kuramoto,et al.  Association of skin cholesterol content, measured by a noninvasive method, with markers of inflammation and Framingham risk prediction. , 2002, The American journal of cardiology.

[11]  R. Wing,et al.  Benefits of recruiting participants with friends and increasing social support for weight loss and maintenance. , 1999, Journal of consulting and clinical psychology.

[12]  Shah Ebrahim,et al.  Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) , 2007 .

[13]  D. Sprecher,et al.  A novel test for the measurement of skin cholesterol. , 2001, Clinical chemistry.

[14]  Robert J Lipsy,et al.  The National Cholesterol Education Program Adult Treatment Panel III guidelines. , 2003, Journal of managed care pharmacy : JMCP.

[15]  Martin O'Flaherty,et al.  Rapid mortality falls after risk-factor changes in populations , 2011, The Lancet.

[16]  R. Karas,et al.  Assessment of peripheral vascular endothelial function in the ambulatory setting , 2007, Vascular medicine.

[17]  Kunio Awazu,et al.  Hyperspectral Imaging of Lipids using Near-infrared Super Continuum Light , 2009 .

[18]  James D. Best,et al.  Impact of Coaching Patients on Coronary Risk Factors , 2005 .

[19]  Dirk De Bacquer,et al.  EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[20]  Richard Kahn,et al.  The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. , 2005, Diabetes care.

[21]  Milton C. Weinstein,et al.  While Lowering Quality Of Life More Americans Living Longer With Cardiovascular Disease Will Increase Costs , 2013 .

[22]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[23]  Victor J Stevens,et al.  Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. , 2003, JAMA.

[24]  K. Kotseva,et al.  EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[25]  Daniel F Leotta,et al.  Flow mediated dilation of the brachial artery: an investigation of methods requiring further standardization , 2007, BMC cardiovascular disorders.

[26]  Simon Capewell,et al.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. , 2007, The New England journal of medicine.

[27]  R. Gans,et al.  Simple non-invasive assessment of advanced glycation endproduct accumulation , 2004, Diabetologia.

[28]  A. Barden,et al.  Advanced Glycation End Products: A Review , 2013 .

[29]  B. J. Gersh Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000 , 2008 .

[30]  R. Kahn,et al.  The metabolic syndrome: time for a critical appraisal , 2005, Diabetologia.

[31]  Rainer Rauramaa,et al.  Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. , 2002, Diabetes care.

[32]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice , 2004 .

[33]  M. Joyner,et al.  Nitric oxide and neurally mediated regulation of skin blood flow during local heating. , 2001, Journal of applied physiology.

[34]  W. Cullen,et al.  Research confuses me: what is the difference between case-control and cohort studies in quantitative research? , 2013, Irish medical journal.

[35]  D. Vanuzzo,et al.  Does surveillance impact on cardiovascular prevention? , 2009, European heart journal.

[36]  R. Krauss,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.

[37]  J. Shaw,et al.  Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[38]  L. Groop,et al.  Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.